Transparency Market Research
(TMR) has published a new report titled, “Bronchitis Treatment Market - Global
Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.
According to the report, the global bronchitis treatment market was
valued at US$ 3,432.62 Mn in 2017. It is projected to expand at a CAGR of 3.6%
during the forecast period. The global bronchitis treatment market is
anticipated to be driven by an increase in mortality and morbidity of
bronchitis during the forecast period. The bronchitis treatment market in Asia
Pacific is expected to expand at a high CAGR of 4.0%, due to the high
prevalence of diseases, improvements in the health care sector, rise in
awareness, and increase in focus on research and development.
Increase in geriatric
population with rise in incidence of bronchitis drive market
The global population is aging
rapidly, especially in a few developed countries such as the U.S., most of
Western Europe, and Japan. Developed economies witness a high rate of aging as
compared to that in developing countries. This is attributed to improved health
care infrastructure, favorable reimbursement policies, and advancements in
health care facilities in these countries. Moreover, access to various
diagnostic and treatment services has improved in recent years, especially in
developed economies. This, in turn, has increased the life expectancy of the
population. The geriatric population is more prone to develop respiratory
conditions. Increase in number of geriatric people leads to high rate of
ailments, which in turn is likely to propel the bronchitis treatment market.
Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=62775
High prevalence of chronic
obstructive pulmonary disease
Chronic Bronchitis is major type
of chronic obstructive pulmonary disease (COPD). COPD is a major health concern
that affects a large number of people across the globe. The disease burden is
increasing among adults and thereby, increasing the need for COPD management.
According to The Global Burden of Disease Study, 251 million COPD cases were
reported in 2016, and 3.17 million deaths were caused due to the disease in
2015. It also reported that COPD accounted for of deaths in low and middle
income countries in 2015. According to the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) 2018, COPD is anticipated to be the
third-leading cause of death by 2020. Increase in mortality and morbidity of
COPD is expected to drive the market
Increasing population of
smokers
Cigarette smoking is a major
cause for the development of chronic bronchitis. The number of smokers are
increasing globally, and while the U.S. has witnessed a decline in the
percentage of people smoking, there are still 40 million adults who smoke, and
20 million are likely to die prematurely, unless they quit. Furthermore,
exposure to secondhand smoke raises complications for people suffering from
bronchitis. Such alarming statistics indicate that the habit of smoking and
increase in number of smokers are likely to propel the bronchitis treatment
market.
Request for Analysis of COVID19 Impact on Bronchitis
Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=62775
The global bronchitis treatment
market has been segmented based on type, drug class, distribution channel, and
region. Furthermore, in terms of type, the market has been divided into chronic
bronchitis and acute bronchitis. The chronic bronchitis segment is likely to
account for a leading share of the global market during the forecast period,
owing to high morbidity and mortality rate. Based on drug class, the bronchitis
treatment market has been classified into antibiotics, anti-inflammatory drugs,
bronchodilators, and mucolytics. In terms of distribution channel, the market
has been segregated into hospital pharmacies, retail pharmacies, and online
pharmacies. The retail pharmacies segment held a significant share of the
market in 2017, due to a rise in the sale of over-the-counter bronchitis
therapeutics.
Increase in incidence of
bronchitis in Asia Pacific to create opportunities in market
In terms of region, the global
bronchitis treatment market has been segmented into five major regions: North
America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America is projected to hold a leading share of the global market during
the forecast period, owing to high awareness, increase research and development
expenditure, and rise in geriatric population. Europe is anticipated to account
for a significant share of the global market between 2018 and 2026. Increase in
incidence of bronchitis is expected to fuel the market in the region during the
forecast period. The market in Asia Pacific is likely to witness robust
expansion during the forecast period, due to a surge in health care
expenditure. Moreover, increasing focus of key players on expansion in Asia
Pacific, large untapped population, and rising awareness about bronchitis
promote the bronchitis treatment market in Asia Pacific. The bronchitis
treatment market in Latin America is anticipated to expand at a steady pace
from 2018 to 2026.
Purchase Bronchitis Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=62775<ype=S
Key players operating in the
global bronchitis treatment market include AstraZeneca, Novartis AG, GlaxoSmithKline
plc, Dr. Reddy's Laboratories Ltd., Melinta Therapeutics, Sanofi Aventis, and
Boehringer Ingelheim International GmbH. Companies operating in the global
bronchitis treatment market focus on strategic collaborations to leverage
footprint in emerging markets such as Asia Pacific and Latin America.
More Trending Reports by Transparency Market Research –
Chronic Myelogenous Leukemia Treatment Market: https://www.biospace.com/article/chronic-myelogenous-leukemia-treatment-market-disease-specific-treatment-to-gain-maximum-revenue-share/
Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
About Us
Transparency Market Research is a
global market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for several decision makers.
Our experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com/
